Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Medicinas Complementares
Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
BMJ Open ; 10(8): e034431, 2020 08 20.
Artigo em Inglês | MEDLINE | ID: mdl-32819929

RESUMO

INTRODUCTION: This clinical trial is designed to evaluate the effect of multiple-dose tranexamic acid (TXA) on perioperative blood loss in patients with rheumatoid arthritis (RA). METHODS AND ANALYSIS: A randomised, single-blinded, parallel-controlled study will be designed. Patients with RA (age 50-75 years) undergoing unilateral primary end-stage total knee arthroplasty will be randomly divided into group A or group B. Group A will be treated with one dose of TXA (1 g; intravenous injection 3 hours postsurgery) and group B with three doses (1 g; intravenous injection at 3, 6 and 12 hours postsurgery) after surgery. The primary outcomes will be evaluated with blood loss, maximum haemoglobin drop and transfusion rate. The secondary outcomes will be evaluated with knee function and complications. ETHICS AND DISSEMINATION: The Shanghai Guanghua Hospital of Integrated Traditional Chinese Medicine and Western Medicine Ethics Committee approved in this study in July 2019. Informed consent will be obtained from all participants. Results of the trial will be published in the Dryad and repository in a peer-reviewed journal. Additionally, deidentified data collected and analysed for this study will be available for review from the corresponding author on reasonable request. TRIAL REGISTRATION NUMBER: ChiCTR1900025013.


Assuntos
Antifibrinolíticos , Artrite Reumatoide , Artroplastia do Joelho , Ácido Tranexâmico , Administração Intravenosa , Idoso , Artrite Reumatoide/tratamento farmacológico , Artrite Reumatoide/cirurgia , Perda Sanguínea Cirúrgica/prevenção & controle , China , Humanos , Pessoa de Meia-Idade , Ensaios Clínicos Controlados Aleatórios como Assunto
2.
Int J Mol Sci ; 15(5): 7827-40, 2014 May 06.
Artigo em Inglês | MEDLINE | ID: mdl-24806341

RESUMO

Ginseng is a popular herb for alleviating menopausal symptoms; however, no conclusive scientific data has shown ginseng as being efficient in such therapies. The present study was designed to evaluate the estrogenic efficacy of ginseng on reproductive target tissues of ovariectomized (OVX) mice. The OVX mice were treated with ginseng at doses of 12.0, 18.0 and 24.0 g/kg per day for four weeks. Ginseng treatments restored the estrus cycle and demonstrated significant estrogenic activity, as indicated by the reversal of the atrophy of the uterus and vagina, upregulation of estrogen receptor (ER) α and ER ß expression at the protein and mRNA level in the reproductive tissues, where ER α upregulation was stronger than that of ER ß. Meanwhile, treatment with ginseng significantly increased adrenal gland weight and serum estradiol and clearly decreased follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in circulation. Notably, the largest changes in these parameters were found at the highest dose of 24.0 g/kg. Moreover, ginseng at 18.0 g/kg resulted in the greatest decrease in weight gain caused by ovariectomy. The data suggest that ginseng estrogenic responses show tissue variation that reflects different affinities of ERs for ginseng components. This study demonstrates that ginseng activity is mediated through estrogenic components and provides further evidence for ginseng treatment of postmenopausal symptoms.


Assuntos
Estrogênios/uso terapêutico , Ovariectomia , Panax , Preparações de Plantas/uso terapêutico , Útero/efeitos dos fármacos , Vagina/efeitos dos fármacos , Animais , Estradiol/sangue , Estrogênios/química , Feminino , Hormônio Luteinizante/sangue , Camundongos , Tamanho do Órgão/efeitos dos fármacos , Ovário/cirurgia , Panax/química , Fitoterapia , Preparações de Plantas/química , Receptores de Estrogênio/análise , Receptores de Estrogênio/genética , Receptores de Estrogênio/metabolismo , Regulação para Cima/efeitos dos fármacos , Útero/patologia , Vagina/patologia
3.
Zhong Xi Yi Jie He Xue Bao ; 4(2): 175-80, 2006 Mar.
Artigo em Chinês | MEDLINE | ID: mdl-16529695

RESUMO

OBJECTIVE: To study the effects of Yiqi Huayu Recipe on neural cell adhesion molecule (N-CAM) in neuromuscular junctions during nerve regeneration in rats with lumbar nerve root compression. METHODS: The rats with lumbar nerve root compression were given Yiqi Huayu Recipe for 10, 20 and 30 days respectively. The distribution of N-CAM in neuromuscular junctions of soleus muscle in rats was examined with immunohistochemical method and confocal laser scanning microscopy technique. The acetylcholine receptor (AChR) was visualized with fluorescein-conjugated alpha-bungarotoxin (alpha-BTX). The overlap areas of N-CAM and AChR sites were measured with NIH image technique. RESULTS: The aggregates, sprouts and extensions of N-CAM in the neuromuscular junctions and the overlap areas of N-CAM and AChR sites in the Yiqi Huayu Recipe-treated group were all better improved than those in the untreated group. CONCLUSION: The expression of N-CAM is regulated according to the state of innervation for muscles. Yiqi Huayu Recipe may accelerate this nerve regeneration process.


Assuntos
Medicamentos de Ervas Chinesas/farmacologia , Síndromes de Compressão Nervosa/metabolismo , Moléculas de Adesão de Célula Nervosa/biossíntese , Raízes Nervosas Espinhais , Animais , Animais Recém-Nascidos , Masculino , Regeneração Nervosa , Moléculas de Adesão de Célula Nervosa/genética , Junção Neuromuscular/metabolismo , Ratos , Ratos Sprague-Dawley , Receptores Colinérgicos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA